Arun Azad
Arun Azad, MBBS, FRACP, PhD
Arun Azad is Professor of Medical Oncology at the University of Melbourne and a Consultant Medical Oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia. Azad has served in leadership roles across multiple international clinical trial steering committees. He is the Translational Chair of the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group and Urologic Oncology Chair at the Clinical Oncology Society of Australia. He also contributes to international standards of care as a member of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines Committee for prostate cancer.
Disclosures: Honoraria from Aculeus Therapeutics, Amgen, Arvinas, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Ipsen, Janssen, Merck Serono, Merck Sharpe Dohme, Novartis, Noxopharm, Pfizer, Sanofi, Telix, and Tolmar. Member of scientific advisory board for Amgen, Arvinas, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Ipsen, Janssen, Merck Serono, Merck Sharpe Dohme, Novartis, Noxopharm, Pfizer, Sanofi, Telix, and Tolmar. Travel and accommodation support from Amgen, Astellas, Bayer, Hinova, Janssen, Merck Serono, Novartis, Pfizer, and Tolmar. Research funding from Aptevo Therapeutics (institutional), Astellas (investigator), Astellas (institutional), AstraZeneca (institutional), AstraZeneca (investigator), Bayer (institutional), Bionomics (institutional), Bristol Myers Squibb (institutional), Eli Lilly (institutional), Exelixis (institutional), Gilead Sciences (institutional), GlaxoSmithKline (institutional), Hinova (institutional), Ipsen (institutional), Janssen (institutional), MedImmune (institutional), Merck Serono (investigator), Merck Serono (institutional), Merck Sharpe Dohme (institutional), Novartis (institutional), Pfizer (institutional), Sanofi (institutional), and SYNthorx (institutional). Member of steering committee for AstraZeneca, Arvinas, Astellas, Exelixis, Janssen, Pfizer, and Merck Sharpe Dohme.
View content featuring Azad:
This content has been developed independently by Medthority who previously received educational funding from Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
of interest
are looking at
saved
next event